The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rybakov O.Yu.

Kutafin Moscow State Law University (MSAL)

Dorodonova N.V.

Kutafin Moscow State Law University (MSAL)

Petrova R.E.

MIREA — Russian Technological University

Rybakova O.S.

Kutafin Moscow State Law University (MSAL)

Legal regulation of the human genome editing technologies application: international standards and the national practices

Authors:

Rybakov O.Yu., Dorodonova N.V., Petrova R.E., Rybakova O.S.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(10): 7‑15

DOI: 10.17116/profmed2025281017

Read: 1619 times

Download PDF (RU)
Contact the author
Table of contents

LEGAL REGULATION OF THE HUMAN GENOME EDITING TECHNOLOGIES APPLICATION: INTERNATIONAL STANDARDS AND THE NATIONAL PRACTICES
LEGAL REGULATION OF THE HUMAN GENOME EDITING TECHNOLOGIES APPLICATION: INTERNATIONAL STANDARDS AND THE NATIONAL PRACTICES

To cite this article:

Rybakov OYu, Dorodonova NV, Petrova RE, Rybakova OS. Legal regulation of the human genome editing technologies application: international standards and the national practices. Russian Journal of Preventive Medicine. 2025;28(10):7‑15. (In Russ.)
https://doi.org/10.17116/profmed2025281017

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Russian Fede­ration public nutritional awareness. Russian Journal of Preventive Medi­cine. 2026;(1):34-39
Prevalence of postpartum depression in the Russian Fede­ration: a systematic review and meta-analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):74-87
Epidemiology of inhe­rited epidermolysis bullosa in the Russian Fede­ration. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):574-582
Comparison of media components and reagents in cultivation and gene­tic editing of human cells A549. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):135-142
Abstract:

The legal regulation of human genome editing for medical and scientific purposes makes possible to apply it in scientific and practical fields. Taking into account that the Russian Federation is not a participant in the formation of the most relevant international documents, there is a necessity to create a national model of the use of biomedical technologies legal regulation considering international standards and approaches.

OBJECTIVE

To study the specifics of the legal regulation in the field of biomedical application of human genome editing technologies at the international and national levels, to determine deficiency or redundancy of this process and to submit proposals for enhancing their effectiveness for minimizing or eliminating the risks of negative consequences.

MATERIALS AND METHODS

A review and analysis of international and national regulatory legal acts in the field of human genome editing technologies application were carried out. Comparative legal and axiological methods were used.

RESULTS

A pressing need to establish detailed regulatory control over innovative biomedical research remains in the Russian Federation. The Chinese model of legal regulation for genome editing is characterized by a systematic approach, clear structure and is based on four key groups of regulatory acts covering biosecurity, the management of genetic resources, research ethics and related aspects.

CONCLUSION

In the legal regulation of human genome editing technologies, it is essential to adhere to constitutional principles that reflect national interests and respect for the individual, protect the rights of citizens, and prevent any forms of discrimination based on an individual’s genetic characteristics. Key objectives include setting priorities in this field, raising public awareness about the possibilities of genetic engineering and ensuring equal access to its application in medicine.

Keywords:

national security
legal regulation of genetic technologies
biomedical technologies
genome editing
ethical and legal regulation
international standards
Russian Federation
the People’s Republic of China

Authors:

Rybakov O.Yu.

Kutafin Moscow State Law University (MSAL)

Dorodonova N.V.

Kutafin Moscow State Law University (MSAL)

Petrova R.E.

MIREA — Russian Technological University

Rybakova O.S.

Kutafin Moscow State Law University (MSAL)

Received:

01.09.2025

Accepted:

12.09.2025

Close metadata

References:

  1. Broeders M, Herrero-Hernandez P, Ernst MPT, et al. Sharpening the Molecular Scissors: Advances in Gene-Editing Technology. iScience. 2020; 23(1):100789. https://doi.org/10.1016/j.isci.2019.100789
  2. Shi M, Shen Z, Zhang N, et al. CRISPR/Cas9 technology in disease research and therapy: a review. Sheng Wu Gong Cheng Xue Bao. 2021; 37(4):1205-1228. https://doi.org/10.13345/j.cjb.200401
  3. Chen C, Wang Z, Qin Y. CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy. Experimental Hematology and Oncology. 2023;12(1):95.  https://doi.org/10.1186/s40164-023-00457-4
  4. Villiger L, Joung J, Koblan L, et al. CRISPR technologies for genome, epigenome and transcriptome editing. Nature Reviews. Molecular Cell Biology. 2024;25(6):464-487.  https://doi.org/10.1038/s41580-023-00697-6
  5. Mir TUG, Wani AK, Akhtar N, et al. CRISPR/Cas9: Regulations and challenges for law enforcement to combat its dual-use. Forensic Science International. 2022;334:111274. https://doi.org/10.1016/j.forsciint.2022.111274
  6. Vseobshhaya deklaraciya prav cheloveka. Rezolyuciya 217 A (III) General`noj Assamblei OON ot 10 dekabrya 1948 g. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/declarations/declhr.html
  7. Mezhdunarodnaya konvenciya o likvidacii vsex form rasovoj diskriminacii. Rezolyuciya 2106 (XX) General`noj Assamblei OON ot 21 dekabrya 1965 g. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/conventions/raceconv.html
  8. Mezhdunarodny`j pakt ob e`konomicheskix, social`ny`x i kul`turny`x pravax, 16 dekabrya 1966 g. Rezolyuciya 2200 (XXI) General`noj Assamblei OON. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/conventions/pactecon.shtml
  9. Konvenciya o likvidacii vsex form diskriminacii v otnoshenii zhenshhin. Rezolyuciya 34/180 General`noj Assamblei OON ot 18 dekabrya 1979 g. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/conventions/cedaw.html
  10. Deklaraciya o pravax invalidov. Rezolyuciya 3447 (XXX) General`noj Assamblei OON ot 9 dekabrya 1975 g. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/declarations/disabled.html
  11. Konvenciya o biologicheskom raznoobrazii (vmeste s «Opredeleniem i monitoringom», «Proceduroj arbitrazhnogo razbiratel`stva», «Soglasitel`noj proceduroj»), Rio-de-Zhanejro, 5 iyunya 1992. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/conventions/biodiv.html
  12. Vseobshhaya deklaraciya o genome cheloveka i pravax cheloveka. General`naya konferenciya OON po voprosam obrazovaniya, nauki i kul`tury`, 11 noyabrya 1997 g. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/declarations/human_genome.html
  13. Mezhdunarodnaya deklaraciya o geneticheskix danny`x cheloveka. Rezolyuciya General`noj konferencii YuNESKO po dokladu Komissii III na 20-m plenarnom zasedanii 16 oktyabrya 2003 g. Accessed September 04, 2025. (In Russ.). https://www.un.org/ru/documents/decl_conv/declarations/genome_dec.shtml
  14. Human genome editing: position paper. WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human. World Health Organization, 2021. Accessed September 04, 2025. https://www.readkong.com/page/recommendations-human-genome-editing-who-expert-advisory-7266507
  15. Evstifeeva EV, Dorodonova NV. International Legal Policy in the Field of Biomedical and Genomic Research. Pravovaja politika i pravovaja zhizn'. 2019;3:44-51. (In Russ.).
  16. Pestrikova AA., Kholopova EN. Risks of Genetic Editing of the Human Genome, Taking into Account the Recommendations of the World Health Organization. Pravovoe gosudarstvo: teorija i praktika. 2022;4(70):47-53. (In Russ.). https://doi.org/10.33184/pravgos-2022.4.7
  17. Pestrikova AA. Perspectives of Genome Editing in Humans: Risks, Problems and Legal Regulation. Medicinskaja jetika. 2022;10(2):28-33. (In Russ.). https://doi.org/10.24075/medet.2022.048
  18. Lapaeva VV. Biotechnological Human Improvement and the Problem of Dehumanization: Philosophical and Law Aspects. Trudy Instituta gosudarstva i prava Rossijskoj akademii nauk. 2022;17(3):11-35. (In Russ.). https://doi.org/10.35427/2073-4522-2022-17-3-lapaeva
  19. Federal’nyj zakon ot 05.07.1996 No. 86-FZ (red. ot 29.12.2022) «O gosudarstvennom regulirovanii v oblasti genno-inzhenernoj dejatel’nosti». Accessed September 04, 2025. (In Russ.). https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=471229&cacheid=5E35C9CADC95EB32083ACE51AE52A62D&mode=splus&rnd=4JCuSA#G0AY6wUS2ooV8PzN1
  20. Federal'nyj zakon ot 29.12.2022 No. 643-FZ «O vnesenii izmenenij v Federal'nyj zakon «O gosudarstvennom regulirovanii v oblasti genno-inzhenernoj dejatel'nosti». Accessed September 04, 2025. (In Russ.). https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=436209&cacheid=90D1AABA85A697DEF1FB2FF5EDCC35EC&mode=splus&rnd=4JCuSA#acrX6wUSiMYuorQg
  21. Federal’nyj zakon ot 21.11.2011 No. 323-F «Ob osnovah ohrany zdorov’ja grazhdan v Rossijskoj Federacii». Accessed September 04, 2025. (In Russ.). https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=502639&cacheid=248B31ED4C278271D73BD66D65A334A7&mode=splus&rnd=4JCuSA#VqaX6wUmiH6bWCs42
  22. Federal’nyj zakon ot 03.12.2008 No. 242-FZ (red. ot 08.08.2024) «O gosudarstvennoj genomnoj registracii v Rossijskoj Federacii». Accessed September 04, 2025. (In Russ.). https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=479642&cacheid=897EB502F81A384DBFCD28B707F2C168&mode=splus&rnd=4JCuSA#8RxW6wUC2NH7jHo51
  23. Federal'naja nauchno-tehnicheskaja programma razvitija geneticheskih tehnologij na 2019—2027 gody, utverzhdena Postanovleniem Pravitel'stva Rossijskoj Federacii ot 22.04.2019 No. 479. Accessed September 04, 2025. (In Russ.). https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=488333&cacheid=696770E7CAB8EEB14A05DAED5BD9E1CB&mode=splus&rnd=4JCuSA#P3kW6wUAzUyILjsB1
  24. Ukaz Prezidenta Rossijskoj Federacii ot 28.02.2024 No. 145 «O Strategii nauchno-tehnologicheskogo razvitija Rossijskoj Federacii». Accessed September 04, 2025. (In Russ.). https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=470973#TMjV6wU29dzNRhHl
  25. Cao C. China’s evolving biosafety/biosecurity legislations. Journal of Law and The Biosciences. 2021;8(1):lsab020. https://doi.org/10.1093/jlb/lsab020
  26. Ping J. From the Perspective of the Operational Mechanisms of Major National Bioethics Committees around the World, the Governance of Technological Ethics. China Reform [Zhongguo Gaige]. 2022;1:79. 
  27. Constitution of the People’s Republic of China 1982. Accessed September 04, 2025. https://www.npc.gov.cn/zgrdw/npc/zt/qt/gjxfz/2014-12/04/content_1888197.html
  28. Ishii T. Germline genome-editing research and its socioethical implications. Trends in Molecular Medicine. 2015;21(8):473-481.  https://doi.org/10.1016/j.molmed.2015.05.006
  29. Greely HT. CRISPR’d babies: human germline genome editing in the ‘He Jiankui affair’. Journal of Law and the Biosciences. 2019;6(1):111-183.  https://doi.org/10.1093/jlb/lsz010
  30. Song L, Joly Y. After He Jianku: China’s biotechnology regulation reforms. Medical Law International. 2021;21(2):174-192.  https://doi.org/10.1177/0968533221993504
  31. Xiaoxiao Zh. Research on the Ethical and Legal Coordination Mechanism of Offspring from the Perspective of Reproductive Genome Editing. Journal of Law and the Biosciences. 2023;45:88.  https://doi.org/10.1093/jlb/lsaf007
  32. Zhang S, Wang Y, Mao D, et al. Current trends of clinical trials involving CRISPR/Cas systems. Frontiers in Medicine. 2023;10:1292452. https://doi.org/10.3389/fmed.2023.1292452
  33. Bharathkumar N, Sunil A, Meera P, et al. CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review. Molecular Biotechnology. 2022;64(4):355-372.  https://doi.org/10.1007/s12033-021-00422-8
  34. Liu G, Lin Q, Jin S, et al. The CRISPR-Cas toolbox and gene editing technologies. Molecular Cell. 2022;82(2):333-347.  https://doi.org/10.1016/j.molcel.2021.12.002
  35. Biosecurity Law of the People’s Republic of China, 2020. Accessed September 04, 2025. https://www.law.pkulaw.com/chinalaw/736cc84db120a6d5bdfb.html
  36. Xue Y, Shang L. Towards Better Governance on Biosafety and Biosecurity: China’s Advances and Perspectives in Medical Biotechnology Legislation. Frontiers in Bioengineering and Biotechnology. 2022;10:939295. https://doi.org/10.3389/fbioe.2022.939295
  37. Regulations on the Management of Human Genetic Resources 2019. Accessed September 04, 2025. www.gov.cn/zhengce/content/2019-06/10/content_5398829.html
  38. Implementation Rules for the Regulations on Human Genetic Resources 2023. Accessed September 04, 2025. https://www.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/bmgz/202306/t20230601_186416.html
  39. Measures for the Ethical Review of Biomedical Research Involving Humans 2007. Accessed September 04, 2025. https://www.nhc.gov.cn/wjw/gfxwj/200703/904f1976ed3d4da49eb56b0edf6e00b2.html
  40. Measures for the Ethical Review of Biomedical Research Involving Humans 2016. Accessed September 04, 2025. https://www.gov.cn/gate/big5/www.beijing.gov.cn/zhengce/zhengcefagui/qtwj/201610/t20161021_780889.html
  41. Liu S. Legal reflections on the case of genome-edited babies. Global Health Research and Policy. 2020;5:24.  https://doi.org/10.1186/s41256-020-00153-4
  42. Measures for Ethical Review of Life Sciences and Medical Research Involving Human Beings 2023. Accessed September 04, 2025. https://www.gov.cn/zhengce/zhengceku/2023-02/28/content_5743658.html
  43. Gang W, Peng H. China Releases Document on Ethics Review of Life Sciences: Comments and Compliance Guidelines. Biotechnology Law Report. 2023;42(3):149-153.  https://doi.org/10.1089/blr.2023.29308
  44. Zou Y, Li Y, Tao Y. Regulatory framework of human germline and heritable genome editing in China: a comparison with the United States and the United Kingdom. Journal of Law and the Biosciences. 2025;12(1):lsaf007. https://doi.org/10.1093/jlb/lsaf007
  45. Trial Measures for Scientific and Technological Ethics Review 2023. Accessed September 04, 2025. https://www.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2023/202310/t20231008_188309.html
  46. Measures for the Supervision and Inspection of Drug Clinical Trial Institutions (for Trial Implementation). 2023. Accessed September 04, 2025. https://www.gov.cn/xxgk/fgwj/xzhgfxwj/20231103175749117.html
  47. Ethical Guidelines for Human Genome Editing. 2024. Accessed September 04, 2025. https://www.gov.cn/kjbgz/202407/t20240708_191311.html
  48. Drug Administration Law of the People’s Republic of China. Accessed September 04, 2025. https://www.gov.cn/zgrdw/englishnpc/Law/2007-12/14/content_1384270.htm
  49. Law on the Progress of Science and Technology. 2021. Accessed September 04, 2025. https://www.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/flfg/202201/t20220118_179043.html
  50. Law of the People’s Republic of China on Basic Medical and Health Care and the Promotion of Health. 2021. Accessed September 04, 2025. https://en.gov.cn/2021-06/26/c_636455.html
  51. Regulations of the National Natural Science Foundation of China. Accessed September 04, 2025. https://www.gov.cn/english/site_1/policy/B3/2017/12-29/41.html
  52. Civil Code of the People’s Republic of China. Accessed September 04, 2025. https://www.gov.cn/xinwen/2020-06/01/content_5516649.html
  53. Criminal Law of the People’s Republic of China. Accessed September 04, 2025. https://www.en.gov.cn.cdurl.cn/2020-12/26/c_921604.html
  54. Wu L, Kong X. A study on the normative path of ethics review in China: based on the perspective of Panopticism. Frontiers in Medicine. 2023;10: 1268046. https://doi.org/10.3389/fmed.2023.1268046
  55. Romanovskiy GB, Romanovskaya OV. Law and Modern Medicine: Issues and Prospects. Izvestija vysshih uchebnyh zavedenij. Povolzhskij region. Obshhestvennye nauki. 2024;1(69):96-110. (In Russ.).
  56. Belova D.A. Protecting the Rights of Persons in Case of Injury Due to the Use of Gene Therapy. Vestnik Universiteta imeni O.E. Kutafina (MGJuA). 2021;1(11):151-159. (In Russ.). https://doi.org/10.17803/2311-5998.2021.87.11.151-159
  57. Chemeris AV, Anisimov VA, Aminev FG. Current Issues of Legal Regulation of Human Genome Databases Creating and Functioning. Pravovoe gosudarstvo: teorija i praktika. 2020;2(60):134-144. (In Russ.). https://doi.org/10.33184/pravgos-2020.2.12
  58. Kubyshkin AV, Grin OS, Shilyuk TO. Legislation of the Russian Federation in the Field of Protection of Genomic and Genetic Information in the Framework of Medical Diagnostics. Obshhaja reanimatologija. 2024; 20(3): 65-74. (In Russ.). https://doi.org/10.15360/1813-9779-2024-3-2395
  59. Pestrikova AA. Advantages and Risks of Editing of the Human Genome — Legal Aspect. Social'nye novacii i social'nye nauki. 2022;4(9):65-75. (In Russ.).
  60. Kopeikin PA. Bioethics, Law and Interests of Future Generations — Some Practical Areas of Common Interest. Medicinskaja jetika. 2024;12(1):42-46. (In Russ.). https://doi.org/10.24075/medet.2024.002
  61. Vasiliev SA, Osavelyuk AM, Burtsev AK, et al. Problems of Legal Regulation of Diagnostics and Editing of the Human Genome in the Russian Federation. Lex Russica. 2019;(6):71-79. (In Russ.). https://doi.org/10.17803/1729-5920.2019.151.6.071-079
  62. Konstitucija Rossijskoj Federacii: prinjata vsenarodnym golosovaniem 12 dekabrja 1993 g. S izmenenijami, odobrennymi v hode obshherossijskogo golosovanija 01 ijulja 2020 g. Accessed September 04, 2025. (In Russ.). https://www.publication.pravo.gov.ru/Document/View/0001202007040001
  63. Kostenkov KA, Komarova VV. Telemedicine and Human Rights: Risks of Interaction. Juridicheskaja nauka i praktika. 2024;2:29-33. (In Russ.).
  64. Grebenshchikova EG, Chuchalin AG. Bioethics in the 21st century: Challenges and Perspectives. Medicinskaja jetika. 2021;9(2):10-15. (In Russ.). https://doi.org/10.24075/medet.2021.012
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.